Author Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial
- PMID: 34697214
- DOI: 10.1212/WNL.0000000000012733
Author Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial
Comment on
-
Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality.Neurology. 2021 May 31;96(22):1052-1054. doi: 10.1212/WNL.0000000000011881. Neurology. 2021. PMID: 33824169 No abstract available.
-
Reader Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.Neurology. 2021 Oct 26;97(17):841. doi: 10.1212/WNL.0000000000012732. Neurology. 2021. PMID: 34697213 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical